Every earnings call for BIOCON — management tone, guidance, KPIs and promise tracking, quarter by quarter.
BIOCON · 6 transcripts · Healthcare · latest Q4 FY26FY26 EBITDA Margin (Adjusted) 22%. Group operating revenue (adjusted) grew 10% YoY.
Read full transcript & analysisOperating Revenue ₹4,173 cr (+9% YoY); EBITDA ₹951 cr (+21% YoY); EBITDA Margin 22%. Group operating revenue grew 9% YoY to INR 4,173 crores.
Read full transcript & analysisOperating Revenue ₹4,296 cr (+20% YoY); EBITDA ₹928 cr (+29% YoY); EBITDA Margin 21%. Group operating revenue of ₹4,296 crores, up 20% YoY.
Read full transcript & analysisOperating Revenue ₹3,942 cr (+15% YoY); Reported EBITDA ₹829 cr (+19% YoY). Operating revenue of INR 3,942 crores, up 15% YoY.
Read full transcript & analysisRevenue from Operations (Q4) ₹4,417 cr (+15% YoY); Reported Net Profit (FY25) ₹1,013 cr. Group Revenue from operations: INR 4,417 crores, up 15% YoY (like-for-like).
Read full transcript & analysisOperating Revenue (Like-for-like) ₹3,821 cr (+10% YoY); Reported Net Profit ₹25 cr. Overall group operating revenue grew 10% YoY (like-for-like) to INR 3,821 crore.
Read full transcript & analysis